Wave Life Sciences Ltd.

WVENASDAQHealthcare● Active

$5.73

$-0.36(-5.91%)

Market Cap$1.1B

P/E Ratio—

52W High$21.73

52W Low$5.02

Avg Volume4.8M

Open$6.08

Beta-1.33

Overview

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Wave Life Sciences Ltd. (WVE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · WVE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.06Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$71.8MFull revenue history

Dividend YieldNo DividendDividend history

Shares Outstanding168.6MShares outstanding history

Next EarningsJul 30, 2026Est.Earnings history

Explore Wave Life Sciences Ltd. Data

Market Cap$1.1B

Analyst Forecast$26 · Buy

DividendsNo Dividend

Revenue$42.7M-60.55%

EarningsEPS $-1.21-72.86%

PE Ratio—

Financial Snapshot

Full Financials

FY 2025Revenue$42.7M▼ 60.55% YoY

202320242025

FY 2025Net Income-$204.4M▼ 110.68% YoY

202320242025

FY 2025EPS$-1.21▼ 72.86% YoY

202320242025

TTM:Revenue: $71.8MNet Income: -$183.6MEPS: $-1.06View income statement →

Analyst Ratings & Price Target

Full Forecast

Buy25 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

12-Month Price Target

$13.00Low

$5.73Current

$26.38Avg Target360.38% upside

$43.00High

Total: 25 · Buy rate: 96.0%

The WVE analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $26.38, representing +360.38% upside from the current price of $5.73.

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

WVE

Wave Life Sciences Ltd.

$5.73-5.91%$1.1B #2

AMLX

Amylyx Pharmaceuticals, Inc.

$13.32-1.39%$1.1B #3

ELVN

Enliven Therapeutics, Inc.

$34.71-1.40%$2.1B #4

NTLA

Intellia Therapeutics, Inc.

$13.54+0.44%$1.5B #5

ORIC

ORIC Pharmaceuticals, Inc.

$7.50-0.13%$776.4M #6

PGEN

Precigen, Inc.

$3.58-1.44%$1.1B

Stock Performance

Full History

1D-0.26%

1W+0.44%

1M-20.40%

3M-56.44%

YTD-66.38%

1Y-18.94%

5Y-21.28%

About Wave Life Sciences Ltd.

CEOPaul Bolno

IPO DateNov 11, 2015

Employees287

CountrySG

Websitewavelifesciences.com

Wave Life Sciences Ltd. a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is de…

Biotechnology HealthcareNASDAQSG

About Stock Overview & Key Data

Wave Life Sciences Ltd. (WVE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 11, 2015. As of the latest trading session, WVE stock price is $5.73, with a market capitalization of $1.1B. The stock has returned -18.94% over the past 12 months and -66.38% year-to-date.

According to 25 Wall Street analysts, the consensus rating for Wave Life Sciences Ltd. stock is Buy, with an average 12-month price target of $26.38. In fiscal year 2025, Wave Life Sciences Ltd. reported revenue of $42.7M and net income of -$204.4M. For detailed data — including Wave Life Sciences Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Wave Life Sciences Ltd. (WVE) stock price is $5.73. The stock is traded on NASDAQ under the ticker symbol WVE. The 52-week range is $5.02 – $21.73.

WVE stock priceWVE quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice